• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CAPIOX® FX ADVANCE HOLLOW FIBER OXYGENATOR W INTEGRATED AF W HARDSHELL RES.; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CAPIOX® FX ADVANCE HOLLOW FIBER OXYGENATOR W INTEGRATED AF W HARDSHELL RES.; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 3CX*FX15RW30C
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/10/2025
Type of Reportable Event Malfunction
Event or Problem Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, there was a pink fluid coming out of both sides of the gas ports.This was an adult case that started (b)(6) evening and ended at 5 am (b)(6).Patient = 89 kg, average flow = 4.5 l/min, line pressure = 215-230 most of the time, mean arterial pressure (map) = 50¿s, sweep rate = 2.3-3 most of the time, activated clotting time (act) = 1000+ the entire case, bypass time = 351 minutes.Patient was not doing great during the case because they had received cardiopulmonary resuscitation (cpr) for 45 min prior to going into the operating room.Patient was also placed on extracorporeal membrane oxygenation (ecmo) and then transitioned to bypass 20 min later.Lowest lactate was 15 to start.Pink fluid not noticed until the end of the case, when they came off bypass and oxygenation was good the entire procedure.No known consequence or health impact to patient, product was not changed out, there was a blood loss of 5cc, procedure was completed successfully.
 
Additional Manufacturer Narrative
Terumo will not receive the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.
 
Additional Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on august 11, 2025.Upon further investigation of the reported event, the following information is new and/or changed: g3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information).H6 (identification of evaluation codes 4114, 3331, 4210, 4315).The actual device was not returned; however, a photo was provided that confirmed the plasma leakage.It is possible that there are unknown factors that contributed to the plasma leakage.Without the actual device returned, a definitive root cause was unable to be determined.The plasma leakage is believed to be a result of prolonged usage which led to the fiber pore surfaces becoming hydrophilic through absorption of elements circulating in the blood over time.A review of the device history records revealed no manufacturing issues related to the reported event.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX® FX ADVANCE HOLLOW FIBER OXYGENATOR W INTEGRATED AF W HARDSHELL RES.
Common Device Name
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer (Section G)
SAME
Manufacturer Contact
douglas patton
125 blue ball road
elkton, MD 21921
7346634145
MDR Report Key22770142
Report Number1124841-2025-00064
Device Sequence Number9120493
Product Code DTZ
UDI-Device Identifier00699753450783
UDI-Public(01)00699753450783(17)270731(10)4K19
Combination Product (Y/N)N
Initial Reporter StateDC
Initial Reporter CountryUS
PMA/510(K) Number
K151389
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number3CX*FX15RW30C
Device Catalogue NumberN/A
Device Lot Number4K19
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/17/2025
Supplement Date Received by Manufacturer09/15/2025
Initial Report FDA Received Date08/11/2025
Supplement Report FDA Received Date10/09/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/21/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
Patient Weight89 KG
-
-